We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
601
Albemarle
ALB
$15.1B
$5.11M 0.03%
23,549
+3,057
+15% +$815K
PAYC icon
602
Paycom
PAYC
$9.52B
$5.11M 0.03%
16,456
+7,086
+76% +$2.29M
CLF icon
603
Cleveland-Cliffs
CLF
$6.99B
$5.1M 0.03%
316,467
-140,109
-31% -$2.11M
NEM icon
604
Newmont
NEM
$124B
$5.09M 0.03%
124,515
+42,794
+52% +$1.91M
CGW icon
605
Invesco S&P Global Water Index ETF
CGW
$1.07B
$5.08M 0.03%
108,864
-5,543
-5% -$255K
USIG icon
606
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$5.08M 0.03%
103,333
-25,742
-20% -$1.25M
SYLD icon
607
Cambria Shareholder Yield ETF
SYLD
$1.02B
$5.07M 0.03%
85,454
+7,785
+10% +$465K
ROL icon
608
Rollins
ROL
$17.6B
$5.03M 0.03%
137,571
-13,651
-9% -$530K
PAVE icon
609
Global X US Infrastructure Development ETF
PAVE
$14.3B
$5.01M 0.03%
189,089
-75,711
-29% -$1.98M
VCR icon
610
Vanguard Consumer Discretionary ETF
VCR
$6.08B
$4.97M 0.03%
22,700
-840
-4% -$197K
GSK icon
611
GSK
GSK
$101B
$4.93M 0.03%
140,403
-31,354
-18% -$1.04M
VALE icon
612
Vale
VALE
$61.4B
$4.93M 0.03%
290,511
+65,339
+29% +$982K
GSUS icon
613
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.3B
$4.92M 0.03%
94,690
+39,171
+71% +$2.05M
HSMV icon
614
First Trust Horizon Managed Volatility Small/Mid ETF
HSMV
$39.2M
$4.91M 0.03%
158,249
-39
-0% -$1.2K
TRV icon
615
Travelers Companies
TRV
$77.2B
$4.91M 0.03%
26,164
+2,670
+11% +$480K
FBT icon
616
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$4.88M 0.03%
31,626
+3,571
+13% +$527K
OEF icon
617
iShares S&P 100 ETF
OEF
$20.4B
$4.86M 0.03%
28,500
-3,793
-12% -$655K
KLAC icon
618
KLA
KLAC
$272B
$4.85M 0.03%
128,660
+10,010
+8% +$349K
COMT icon
619
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.23B
$4.84M 0.03%
171,540
-6,813
-4% -$243K
PPL
620
PPL Corp
PPL
$26.7B
$4.81M 0.02%
164,584
-11,756
-7% -$323K
SPYX icon
621
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.87B
$4.78M 0.02%
153,657
+9,903
+7% +$308K
MRO
622
DELISTED
Marathon Oil Corporation
MRO
$4.75M 0.02%
175,315
-9,512
-5% -$276K
EXC icon
623
Exelon
EXC
$46.6B
$4.74M 0.02%
109,699
-2,645
-2% -$104K
MEAR icon
624
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
$4.73M 0.02%
95,086
+1,715
+2% +$85.2K
HACK icon
625
Amplify Cybersecurity ETF
HACK
$3B
$4.72M 0.02%
107,144
-3,816
-3% -$171K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.